VEGFA and prostate carcinoma: Several proangiogenic molecules, including VEGF (vascular endothelial growth factor), IL-8, and MMP9, have been shown to be downregulated in prostate cancer and hemangioma tumor cells [91], and inhibition of NF-κB in these cells blocked their ability to promote angiogenesis.